Revvityブログ
発見から治療までのイノベーションを促進
Latest
From policy to practice: what FDA's 2025 direction means for your precision medicine pipeline.
Cell and Gene Therapy
December 8, 2025 - 5 min read
Drug Development
Revvity Omics: expertise in drug development, from inception to market.
March 25, 2024 -
3 min read
Infectious Diseases
A delegate’s reflections from the 75th World Health Assembly.
March 15, 2024 -
3 min read
Infectious Diseases
Pomegranate peel extract shows promising antiviral effects against COVID-19.
March 15, 2024 -
4 min read
Drug Development
An overview of RAS protein mutations in cancer and KRAS-targeted therapeutics.
March 15, 2024 -
4 min read
Biologics
Researchers develop novel assay for simultaneous measurement of bsAb target binding.
March 15, 2024 -
2 min read
